SRL Diagnostics, an arm of Fortis Healthcare, is likely to be listed on the stock exchanges in 2019.
IHH Healthcare Bhd of Malaysia, which is in the process of taking over SRL, has plans to take the brand to markets abroad in the medium to long term, sources claimed.
Meanwhile, IHH would be infusing about Rs 20 billion to meet additional fund requirements of Fortis Group. It has already infused Rs 40 billion as part of an earlier deal.
The additional fund infusion